A statistical perspective to the QTc interval in the treatment of COVID-19.
作者信息
Mert Kadir Ugur, Turk Ugur Onsel, Gorenek Bulent
机构信息
Eskisehir Osmangazi University, Faculty of Medicine, Department of Cardiology, Eskisehir, Turkey.
Izmir Economy University, Faculty of Medicine, Department of Cardiology, Izmir, Turkey.
出版信息
J Electrocardiol. 2021 May-Jun;66:48. doi: 10.1016/j.jelectrocard.2021.03.002. Epub 2021 Mar 16.
Abstract
摘要
相似文献
1
A statistical perspective to the QTc interval in the treatment of COVID-19.新冠肺炎治疗中QTc间期的统计学视角
J Electrocardiol. 2021 May-Jun;66:48. doi: 10.1016/j.jelectrocard.2021.03.002. Epub 2021 Mar 16.
2
Effect of hydroxychloroquine, azithromycin and lopinavir/ritonavir on the QT corrected interval in patients with COVID-19.羟氯喹、阿奇霉素和洛匹那韦/利托那韦对 COVID-19 患者 QT 校正间期的影响。
J Electrocardiol. 2021 Jan-Feb;64:30-35. doi: 10.1016/j.jelectrocard.2020.11.012. Epub 2020 Nov 28.
3
Effects on QT interval of hydroxychloroquine associated with ritonavir/darunavir or azithromycin in patients with SARS-CoV-2 infection.羟氯喹联合利托那韦/达芦那韦或阿奇霉素对 SARS-CoV-2 感染患者 QT 间期的影响。
Heart Vessels. 2021 Jan;36(1):115-120. doi: 10.1007/s00380-020-01671-4. Epub 2020 Jul 16.
4
QTc prolongation in COVID-19 patients treated with hydroxychloroquine, chloroquine, azithromycin, or lopinavir/ritonavir: A systematic review and meta-analysis.在接受羟氯喹、氯喹、阿奇霉素或洛匹那韦/利托那韦治疗的 COVID-19 患者中出现 QTc 延长：系统评价和荟萃分析。
Pharmacoepidemiol Drug Saf. 2021 Jun;30(6):694-706. doi: 10.1002/pds.5234. Epub 2021 Apr 3.
5
6
"Off-label" use of hydroxychloroquine, azithromycin, lopinavir-ritonavir and chloroquine in COVID-19: A survey of cardiac adverse drug reactions by the French Network of Pharmacovigilance Centers.羟氯喹、阿奇霉素、洛匹那韦-利托那韦和氯喹在 COVID-19 中的“超适应证”使用：法国药物警戒中心网络对心脏不良药物反应的调查。
Therapie. 2020 Jul-Aug;75(4):371-379. doi: 10.1016/j.therap.2020.05.002. Epub 2020 May 7.
7
QTc interval prolongation in patients infected with SARS-CoV-2 and treated with antiviral drugs.感染 SARS-CoV-2 病毒并接受抗病毒药物治疗的患者的 QTc 间期延长。
An Pediatr (Engl Ed). 2022 Mar;96(3):213-220. doi: 10.1016/j.anpede.2021.04.006. Epub 2022 Feb 19.
8
Off-label use of chloroquine, hydroxychloroquine, azithromycin and lopinavir/ritonavir in COVID-19 risks prolonging the QT interval by targeting the hERG channel.氯喹、羟氯喹、阿奇霉素和洛匹那韦/利托那韦在 COVID-19 中的超适应证使用通过靶向 hERG 通道而延长 QT 间期。
Eur J Pharmacol. 2021 Feb 15;893:173813. doi: 10.1016/j.ejphar.2020.173813. Epub 2020 Dec 18.
9
Clinical guidance for navigating the QTc-prolonging and arrhythmogenic potential of pharmacotherapy during the COVID-19 pandemic.COVID-19 大流行期间药物治疗致 QTc 延长和致心律失常潜能的临床指导。
Ir J Med Sci. 2021 Feb;190(1):403-409. doi: 10.1007/s11845-020-02291-7. Epub 2020 Jul 6.
10
QT Interval Monitoring with Handheld Heart Rhythm ECG Device in COVID-19 Patients.手持式心搏节律心电图设备在 COVID-19 患者中的 QT 间期监测。
Glob Heart. 2021 Jun 8;16(1):42. doi: 10.5334/gh.916.
引用本文的文献
1
User Perceptions and Experiences of a Handheld 12-Lead Electrocardiographic Device in a Clinical Setting: Usability Evaluation.临床环境中手持12导联心电图设备的用户认知与体验：可用性评估
JMIR Cardio. 2021 Aug 26;5(2):e21186. doi: 10.2196/21186.
本文引用的文献
1
Effect of hydroxychloroquine, azithromycin and lopinavir/ritonavir on the QT corrected interval in patients with COVID-19.羟氯喹、阿奇霉素和洛匹那韦/利托那韦对 COVID-19 患者 QT 校正间期的影响。
J Electrocardiol. 2021 Jan-Feb;64:30-35. doi: 10.1016/j.jelectrocard.2020.11.012. Epub 2020 Nov 28.
2
Comparison of acute management of atrial fibrillation in heart failure with unequal sized groups.
Am J Emerg Med. 2018 Sep;36(9):1693. doi: 10.1016/j.ajem.2018.06.046. Epub 2018 Jun 19.
3
Is electrical cardioversion doable in atrial fibrillation without transesophageal echocardiography?
Int J Cardiol. 2017 Nov 15;247:20. doi: 10.1016/j.ijcard.2017.04.042.
4
Statistics notes: Analysing controlled trials with baseline and follow up measurements.统计学笔记：分析具有基线和随访测量的对照试验。
BMJ. 2001 Nov 10;323(7321):1123-4. doi: 10.1136/bmj.323.7321.1123.
Zotero 插件